Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Patients With Alpha Coronavirus Variant Do Not Carry More Virus In Upper Respiratory Tract, Data Indicate

    Healio (6/30, Stulpin) reports, “Patients with the alpha variant of SARS-CoV-2 do not carry more virus in their upper respiratory tract despite increased transmissibility, according to” researchers who evaluated “if patients had higher viral loads and, co...
    Full Article
  • Serum miRNA Differentially Contributes To Asthma Pathogenesis In Patients 65 Years And Older, Study Says

    Pulmonology Advisor (6/30, Schad) reports, “Serum microRNA (miRNA) may differentially contribute to asthma pathogenesis in older (> 65 years old) vs younger (30 to 50 years old) patients, according to” findings from a 59-patient study (6/10, Wardzyńska) p...
    Full Article
  • Gene Variant Could Be Driving High Rates Of Unnecessary Bone Marrow Biopsies In Black Patients, Researchers Say

    HealthDay (6/30, Preidt) reports that “a gene variant may be driving high rates of unnecessary bone marrow biopsies in Black Americans, researchers say.” This “variant is responsible for lower white blood cell levels in some healthy Black people, the inve...
    Full Article
  • Immunogenicity Of Bivalent, Quadrivalent HPV Vaccines Correlated To Cross-Protective Efficacy, Study Indicates

    Infectious Disease Advisor (6/30, Aghjayan) reports, “Immunogenicity of bivalent and quadrivalent human papillomavirus (HPV) vaccines are correlated to their cross-protective efficacy, with significant differences in induced antibody concentrations 2 to 1...
    Full Article
  • Large-Scale Drug Price Increases For Antiparasitic Medication Associated With Higher Outpatient Treatment Costs, Researchers Say

    Healio (6/25, Dreisbach) reports large-scale drug price rises “for antiparasitic medication were associated with increased total outpatient treatment costs, or TOCs, researchers” concluded in a cross-sectional study on “the association between antiparasit...
    Full Article
  • Low-Dose VBI-2601 Vaccine Safe, Effective In Patients With Chronic Hepatitis B, Results Suggest

    Healio (6/30, Marabito) reports, “A treatment regimen of low dose VBI-2601 (BRII-179) injections in patients with chronic hepatitis B exhibited positive safety, tolerability and efficacy, according to” findings presented during the International Liver Con...
    Full Article
  • CureVac’s Vaccine Just 48% Effective Against COVID-19, Final Phase 3 Trial Results Show

    The New York Times (6/30, Zimmer) reports CureVac on Wednesday issued “the final results of its late-stage vaccine trial, confirming earlier data showing that its” COVID-19 vaccine candidate “is far less protective than other vaccines,” reaching “an effic...
    Full Article
  • Moderna COVID-19 Vaccine Produces Antibodies Against Delta Variant, Preprint Study Suggests

    Reuters (6/29, Roy) reports Moderna’s COVID-19 vaccine “showed promise against the Delta” coronavirus variant “in a lab study, with a modest decrease in response compared to the original strain.” The study “was conducted on blood serum from eight particip...
    Full Article
  • Test Restriction Intervention More Effective Than EHR-Based Support In Reducing C. Diff Testing, Research Suggests

    Healio (6/29, Stulpin) reports, “An intervention that required administrative approval of all Clostridioides difficile [C. Diff] testing after hospital day 3 out-performed electronic health record-based support in reducing C. difficile testing,” researche...
    Full Article
  • Fidaxomicin More Effective Than Metronidazole, Vancomycin For C. Diff Shedding Reduction, Study Says

    Infectious Disease Advisor (6/29, Nye) reports trial results published in Clinical Infectious Diseases showed that Clostridioides difficile (C. diff) shedding was “more effectively reduced with fidaxomicin therapy compared with vancomycin and metronidazol...
    Full Article
  • Fostemsavir Tied To Sustained Virologic Response In Heavily Treatment-Experienced HIV-1, Results Show

    Infectious Disease Advisor (6/29, Lee) reports fostemsavir therapy “in heavily treatment-experienced patients with HIV-1 was found to be associated with sustained virologic response rates through 96 weeks of treatment, according to” phase 3 clinical findi...
    Full Article
  • Researchers Recommend Novel Definition For Extensively Drug-Resistant Tuberculosis

    Pulmonology Advisor (6/29, Alvarez) reports a recent study published in the American Journal of Respiratory and Critical Care Medicine “suggested a new definition of extensively drug-resistant tuberculosis (XDR-TB) as multidrug resistant (MDR) plus additi...
    Full Article
  • Rhode Island Resident Diagnosed With Powassan Virus Disease

    The AP (6/29) reports that on Tuesday, a healthy Rhode Island resident, who is over the age of 70, has been diagnosed with Powassan virus disease, “a rare tick-borne disease that can cause muscular weakness or even paralysis.” The CDC confirmed the case,...
    Full Article
  • CCTA Detects Higher Incidence Of Coronary Plaque Among HIV-Positive People Despite Cardiovascular Disease Risk, Study Indicates

    Aunt Minnie (6/29, Madden Yee) reports “coronary CT angiography (CCTA) shows that HIV-positive people have higher incidence of coronary plaque – even if they are at low to moderate risk for cardiovascular disease,” research suggests. The study published i...
    Full Article
  • US COVID-19 Contact Tracers Seeking To Track Delta Variant Spread

    The Wall Street Journal (6/29, McKay, Subscription Publication) examines the efforts of US COVID-19 contact tracers as active infections continue to plummet throughout the country even as the Delta variant is expected to spread. State COVID-19-tracking ef...
    Full Article
  • Pfizer-BioNTech, Moderna COVID-19 Vaccines Likely Provide “Vast Majority” Of Recipients With Long-Term Immunity, Researchers Say

    The New York Times (6/28, Mandavilli) reports a new study published in Nature has found the COVID-19 vaccines from Pfizer-BioNTech and Moderna “set off a persistent immune reaction in the body that may protect against the coronavirus for years, scientists...
    Full Article
  • Rectal, Stool Samples Detect Enteropathogens In Children With Isolated Vomiting, Study Says

    Infectious Disease Advisor (6/28, Mermelstein) reports, “Rectal swabs and stool samples identified an enteropathogen in more than half of children who presented with isolated vomiting, and nearly one-third of the pathogens were noroviruses, according to”...
    Full Article
  • Treatment With Low-Dose Azithromycin For Chronic Cough In Patients With Idiopathic Pulmonary Fibrosis Did Not Significantly Improve Cough-Related Quality Of Life, Study Finds

    Healio (6/28, Welsh) reports, “Treatment with low-dose azithromycin for chronic cough in patients with idiopathic pulmonary fibrosis did not significantly improve cough-related quality of life, severity or frequency compared with placebo.” This “randomize...
    Full Article
  • Delta Coronavirus Variant Surge Prompts New Restrictions Worldwide

    The Washington Post (6/28, Cunningham) reports, “The rapid spread of the delta coronavirus variant has forced a growing number of countries to reimpose lockdowns and other public health restrictions, raising fears that the more contagious variant was hamp...
    Full Article
  • On-Site PrEP Access Cuts HIV Incidence By Half, Study Finds

    Healio (6/24, Dreisbach) reports, “On-site access to PrEP during a clinical trial reduced HIV incidence by around 50%,” researchers concluded in a “time-series study of 2,124 women from South Africa from nine sites where access to oral PrEP was initiated...
    Full Article
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id